Franklin Resources
LBRX icon

Franklin Resources’s LB Pharmaceuticals LBRX Stock Holding History

Franklin Resources’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$374K Buy
+9,145
New +$378K ﹤0.01% 2654

Other funds holding LBRX

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
HighVista Strategies
HighVista Strategies Boston, Massachusetts $381M AUM 124.67% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Longbow Finance
Longbow Finance Lutry, Switzerland $850M AUM 42.98% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Franklin Resources's LBRX Position: Q3 2026 in Review

Franklin Resources opened a new position in LB Pharmaceuticals (LBRX) in Q3 2026: 9,145 shares worth $374K. The stake represents ﹤0.01% of the portfolio and ranks #2654 among its holdings.

71 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • Franklin Resources held 9,145 shares of LB Pharmaceuticals worth $374K as of Q3 2026.
  • LB Pharmaceuticals was a new Franklin Resources position in Q3 2026.
  • LB Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #2654 holding.
  • 71 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.